Episode 9 - Analyzing Incentive Programs

Together, experts Peter Salgo, MD; John L. Fox, MD, MHA; Ira M. Klein, MD, MBA, FACP; Michael Kolodziej, MD; and Bryan Loy, MD, analyze programs that are aimed at helping to control the high costs associated with the treatment of cancer while driving quality.

Dr Loy explains that collaboration between payers and organizations such as ASCO and NCCN continues to be a success. As these organizations continue to update and/or establish new guidelines, they are very receptive to feedback and use the information to modify their recommendations, he says. Dr Loy adds that specific programs such as the work of the National Business Group on Health ensure that large employers also have the opportunity to share considerations with payers in terms of how the cancer experience affects them.

Because treatment complications are a major concern, the establishment of specific pathways can help limit the number of adverse events and guide therapy; and the use of pathways is particularly beneficial because they can help guide care in cancers where several treatment options are available, says Dr Fox.

Internal server error